3 Pharma Stocks That Are Too Cheap to Ignore
Are stocks expensive? Many of them are. Valuations are sky-high after the massive gains generated over the last decade. However, not all stocks trade at nosebleed levels.
We asked three Motley Fool contributors to pick pharma stocks that remain attractively valued. Here's why they think Bristol Myers Squibb (NYSE: BMY), Novartis (NYSE: NVS), and Viatris (NASDAQ: VTRS) are too cheap to ignore.
Image source: Getty Images.
Source Fool.com
